Prognostic value of multiple biomarkers for kidney function decline in type 2 diabetes with relatively preserved kidney function: a systematic review and exploratory meta-analysis
- 1Department of Endocrinology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
- 2Graduate School, Beijing University of Chinese Medicine, Beijing, China
Abstract
Background: Diabetic kidney disease (DKD) is a dominant driver of chronic kidney disease (CKD) and end-stage renal disease (ESRD). Current risk assessment tools, however, lack adequate sensitivity for early disease detection. This study evaluated the prognostic value of multiple biomarkers for kidney function decline in patients with type 2 diabetes and relatively preserved kidney function.
Methods: This systematic review and meta-analysis followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. PubMed, EMBASE, Web of Science, and the Cochrane Library were searched from inception to December 31, 2025. Articles were independently screened by two reviewers against pre-specified criteria. Prospective cohort studies reporting associations between baseline biomarkers and kidney function decline were included. Methodological quality was assessed using the Quality In Prognosis Studies (QUIPS) tool. Quantitative pooling was performed only when studies were homogeneous in effect measure and outcome definition. When these criteria were not met, results were presented descriptively.
Results: Nine prospective cohort studies comprising 4,569 participants were included. Circulating TNFR1, TNFR2, and KIM-1 showed potential positive associations with kidney function decline. One study reported an inverse association for circulating Klotho. No significant associations were found for circulating FGF-23. Findings for urinary NGAL and urinary KIM-1 were inconsistent across studies. Due to heterogeneity in effect measures, exposure scales, and outcome definitions, several biomarkers could not be quantitatively pooled. For pooled analyses, each analysis included only two studies; therefore, effect estimates, heterogeneity, and prediction intervals may be unstable, and the results should be considered exploratory.
Conclusions: Current evidence suggests potential associations of circulating TNFR1, TNFR2, and KIM-1 with kidney function decline in type 2 diabetes with relatively preserved kidney function. Given the limited number of studies, these findings are exploratory and require validation in larger prospective studies with standardized assays and outcome definitions.
Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/, identifier CRD420261401816.
Related
- Supine hypertension as a distinct phenotype of neurogenic orthostatic hypotension with relatively preserved clinical function in Parkinson’s disease
- Severe Suspected Metformin-Associated Lactic Acidosis With Relatively Preserved Serum Creatinine at Presentation: Sequential Intermittent Hemodialysis and Continuous Venovenous Hemodialysis.
- Lymphatic Microvascular Density, Lymphatic Invasion and Endothelial Cell Proliferation as Prognostic Biomarkers in Cutaneous Melanoma: A Systematic Review and Evidence Map
- Relatively preserved cognition despite elevated adjusted serum neurofilament light in U.S. adults aged 60–75 years: a survey-weighted NHANES analysis
- Multimodal Large Language Models for Prognostic Prediction in Cervical Cancer Treated with Definitive Chemoradiotherapy: An Exploratory Study of Systematic Multimodal Data Integration.
BibTeX
@article{hu2026prognostic,
title = {{Prognostic value of multiple biomarkers for kidney function decline in type 2 diabetes with relatively preserved kidney function: a systematic review and exploratory meta-analysis}},
author = {Jie Hu and Xinyu Pan and Shuwu Wei and Junping Wei},
journal = {Frontiers in Endocrinology},
year = {2026},
month = oct,
doi = {10.3389/fendo.2026.1938521},
url = {https://doi.org/10.3389/fendo.2026.1938521},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Prognostic value of multiple biomarkers for kidney function decline in type 2 diabetes with relatively preserved kidney function: a systematic review and exploratory meta-analysis
AU - Jie Hu
AU - Xinyu Pan
AU - Shuwu Wei
AU - Junping Wei
PY - 2026
DA - 2026/10/12
JO - Frontiers in Endocrinology
DO - 10.3389/fendo.2026.1938521
UR - https://doi.org/10.3389/fendo.2026.1938521
AB - Background: Diabetic kidney disease (DKD) is a dominant driver of chronic kidney disease (CKD) and end-stage renal disease (ESRD). Current risk assessment tools, however, lack adequate sensitivity for early disease detection. This study evaluated the prognostic value of multiple biomarkers for kidney function decline in patients with type 2 diabetes and relatively preserved kidney function. Methods: This systematic review and meta-analysis followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. PubMed, EMBASE, Web of Science, and the Cochrane Library were searched from inception to December 31, 2025. Articles were independently screened by two reviewers against pre-specified criteria. Prospective cohort studies reporting associations between baseline biomarkers and kidney function decline were included. Methodological quality was assessed using the Quality In Prognosis Studies (QUIPS) tool. Quantitative pooling was performed only when studies were homogeneous in effect measure and outcome definition. When these criteria were not met, results were presented descriptively. Results: Nine prospective cohort studies comprising 4,569 participants were included. Circulating TNFR1, TNFR2, and KIM-1 showed potential positive associations with kidney function decline. One study reported an inverse association for circulating Klotho. No significant associations were found for circulating FGF-23. Findings for urinary NGAL and urinary KIM-1 were inconsistent across studies. Due to heterogeneity in effect measures, exposure scales, and outcome definitions, several biomarkers could not be quantitatively pooled. For pooled analyses, each analysis included only two studies; therefore, effect estimates, heterogeneity, and prediction intervals may be unstable, and the results should be considered exploratory. Conclusions: Current evidence suggests potential associations of circulating TNFR1, TNFR2, and KIM-1 with kidney function decline in type 2 diabetes with relatively preserved kidney function. Given the limited number of studies, these findings are exploratory and require validation in larger prospective studies with standardized assays and outcome definitions. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/, identifier CRD420261401816.
SN - 1664-2392
ER -